NCT00349557View on ClinicalTrials.gov

Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2006

Conditions
Prostate Cancer
Interventions
DRUG

bevacizumab, bicalutamide and goserelin

PROCEDURE

intensity modulated radiation therapy (IMRT)

Trial Locations (1)

98101

Virginia Mason Medical Center, Seattle

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Benaroya Research Institute

OTHER